BeyondSpring Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BeyondSpring Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $2.97M.
- BeyondSpring Inc. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $80.20M, a 239.70% increase year-over-year.
- BeyondSpring Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $5.00M, a 87.35% decline year-over-year.
- BeyondSpring Inc. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $23.61M.
- BeyondSpring Inc. stock issued during period, value, new issues for fiscal 2025 was $1.98M, a 33.33% decline from fiscal 2024.
- BeyondSpring Inc. stock issued during period, value, new issues for fiscal 2024 was $2.97M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $1.98M 10-K · filed 2026-03-25 | |
| 2024-12-31 | $2.97M 10-K · filed 2026-03-25 | |
| 2024-06-30 | $2.97M 10-Q · filed 2025-11-12 | |
| 2020-12-31 | $80.20M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $111.59M 20-F · filed 2023-04-18 |
| 2020-09-30 | $5.00M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | |
| 2019-12-31 | $23.61M derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $68.57M 20-F · filed 2022-04-14 |
| 2019-09-30 | $39.53M derived: 6-K 9 month − 6-K 6 month · filed 2020-11-17 | |
| 2018-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $13.24M 20-F · filed 2021-04-30 |
| 2018-09-30 | -$100.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18 | |
| 2017-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $89.44M 20-F · filed 2020-04-30 |
| 2017-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $89.44M derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2018-10-23 | |
| 2017-03-31 | $89.44M 6-K · filed 2018-06-21 | |
| 2016-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | $15.25M 20-F · filed 2019-04-30 |
| 2015-12-31 | $16.00M 20-F · filed 2018-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |